HeartBeam Reports Fourth Quarter and Full Year 2022 Financial Results
Heartbeam, Inc. (BEAT)
Last heartbeam, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
gobio.com/investors/news-releases
Company Research
Source: Business Wire
Acquired Assets from LIVMOR, Extending Reach in Remote Monitoring and Detection with an Existing Cutting Edge FDA-Cleared Product, Halo+™ Atrial Fibrillation Detection SystemPartnered with Evolve Manufacturing to Build HeartBeam AIMIGo 12-Lead 3D Vector Electrocardiogram DeviceReceived European Patent for HeartBeam AIMIGo TechnologyInitial FDA Submission of HeartBeam AIMIGo™, the Telehealth Solution, Projected for Q2 2023Management to Host Webcast and Conference Call Today At 4:30 p.m. ET SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D vector electrocardiogram (VECG) platform for heart attack detection anytime, anywhere, has reported its financial and operational results for the fourth quarter and full year ended December 31, 2022.Fourth Quarter and Subsequent 2023 Operational HighlightsStrategic acquisition (the “Acquisition”) of substantially all assets from LIVMOR, a digital health soluti
Show less
Read more
Impact Snapshot
Event Time:
BEAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BEAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BEAT alerts
High impacting Heartbeam, Inc. news events
Weekly update
A roundup of the hottest topics
BEAT
News
- Credit-Card Sized Device Wins FDA Clearance for At-Home Heart Monitoring [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Top Midday Gainers [Yahoo! Finance]Yahoo! Finance
- HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia AssessmentBusiness Wire
- HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software ApplicationBusiness Wire
- HeartBeam (BEAT) Recognized as a Top Global Innovator in Portable ECG Technology [Yahoo! Finance]Yahoo! Finance
BEAT
Earnings
- 11/13/25 - Beat
BEAT
Sec Filings
- 12/22/25 - Form 4
- 12/19/25 - Form 4
- 11/21/25 - Form 8-K
- BEAT's page on the SEC website